Healthtech Startups

Ennoble Care provides personalized in-home primary care, hospice, and palliative care services to patients. The company delivers compassionate healthcare focused on individualized patient support and well-being.

1 investor

Enov.one is a telehealth service offering personalized longevity and hormone optimization care, including bio-identical hormone balancing (for optimization, peri- and post-menopause) and pharmaceutical-grade medications and supplements such as B12, NAD+, and GSH. It uses an online assessment and AI, optionally combined with lab or DNA results, to connect patients with board-certified doctors and address conditions like fatigue, brain fog, mood imbalances, and weight management, serving 48 of 50 US states.

1 investor

Enrich Biosystems develops TROVO, a fluidics-free benchtop instrument that compartmentalizes standard culture plates into thousands of hydrogel microwells for high-throughput functional screening, imaging, and live recovery of cells. It serves cell therapy and life sciences researchers working on applications such as CAR-T cell selection, cell line development, and single-cell omics enrichment.

1 investor

Fundación INTRAS is a nonprofit organization running an R&D and innovation program that co-creates assistive and digital health technologies with end users, professionals, and the public for mental health, dementia, elderly care, and long-term social-health care. Its research covers areas such as AI, social robotics, virtual reality, and rehabilitation systems, with results transferred to market through its spin-off IDES.

1 investor

Entasis Therapeutics is a biotechnology company developing and marketing therapies for critical care and infectious diseases, focusing on serious conditions with high unmet need. Its products include GIAPREZA, NUZOLVENCE, XACDURO, XERAVA, and ZEVTERA.

1 investor

Entegrion develops a point-of-care viscoelastic coagulation monitoring system (VCM) for rapid hemostasis assessment in clinical settings including trauma, surgery, and obstetrics. The company serves clinicians in civilian and military medicine, with regulatory clearance in Europe.

1 investor

Entelai develops clinically validated artificial intelligence tools for medicine, including diagnostic support for neurological conditions such as multiple sclerosis and headache assessment via brain MRI analysis. It serves healthcare professionals, medical institutions and patients across Latin America, and also offers an online service for medical prescriptions and studies.

1 investor

1 investor

Entelo Bio operates an insights platform that analyzes disease biology at high resolution to support precision medicine. The company focuses on applications in human resilience.

1 investor

Enteral Access Technologies develops medical devices for safe placement of nasogastric feeding and decompression tubes in clinical settings. The company manufactures DoubleCHEK™, a combined CO2 and pH indicator device that reduces misplacement risk and unnecessary radiation exposure.

1 investor

EnteraSense is a medical device company that develops sensor-based diagnostic technology for gastrointestinal care, notably Pillsense, a tool to detect and monitor upper gastrointestinal bleeding. Founded in 2015, it works in partnership with Brigham and Women's Hospital/Harvard Medical School and serves clinical/healthcare providers.

1 investor

EnteroBiotix is a clinical-stage microbiome therapeutics company developing EBX-102-02, an orally delivered, full-spectrum microbiome drug for irritable bowel syndrome and other gastrointestinal and liver diseases. It uses proprietary AMPLA drying technology and MHRA-licensed GMP manufacturing, with a pipeline spanning IBS, liver cirrhosis, and adjuvant treatment in blood cancer.</parameter> <parameter name="founders">[]

1 investor

Entero Healthcare Solutions is a healthcare products distribution company operating in India, connecting pharmaceutical manufacturers with pharmacies and healthcare providers. The company is publicly listed in India following an initial public offering.

1 investor

1 investor

Entia develops at-home blood monitoring solutions for healthcare providers and patients. The company aims to reduce treatment burden and healthcare system disruption by integrating monitoring technology into daily life.

1 investor

EntityMed provides an AI-powered facial simulator tool for aesthetic practices to generate patient leads and enable potential clients to preview cosmetic treatment outcomes. The platform includes lead capture, a built-in CRM, and integrations with marketing channels for aesthetic clinics and medical spas.

1 investor

NextGen Mobile is a mobile EHR application for healthcare providers that integrates clinical AI capabilities including ambient listening, voice dictation, and automated note generation to reduce documentation time. The platform enables physicians and clinical staff to manage patient workflows, e-prescribe, and handle administrative tasks directly from mobile devices.

1 investor

Entropy provides an AI-powered operating system for specialty healthcare practices that automates patient intake, eligibility verification, prior authorization, and revenue cycle management. The platform integrates with existing EHR and billing systems to reduce administrative workload and accelerate claims processing.

1 investor

Entvin develops AI agents for regulatory teams in life sciences companies, automating compliance workflows and approval processes while maintaining data security.

1 investor

Enumera Molecular develops technology and a platform for simplified, lower-cost workflows that enable liquid biopsy and high-dimensional omics assays for laboratories. It targets clinical labs performing molecular diagnostics.

1 investor

Enviro-Fresh manufactures sealed compartment storage systems for towels and linens in healthcare facilities and hospitality settings. The product reduces laundering costs and environmental impact while maintaining hygiene standards through tamper-evident indicators.

1 investor

EnVision Endoscopy develops medical devices for gastrointestinal endoscopic surgery, including an Image Guided Suturing System for tissue approximation and management of gastrointestinal defects. The company aims to improve patient outcomes and reduce healthcare costs for endoscopy procedures.

1 investor

Envision Pharma Group provides strategic consulting and technology services to biopharma companies across asset strategy, product commercialization, medical affairs optimization, and revenue management. The company serves pharmaceutical manufacturers of all sizes with integrated services spanning clinical evidence generation, market access, compliance, and AI-driven platforms.

1 investor

Envisionit Deep AI builds RATIFY, a vendor-agnostic AI assurance platform for radiology that validates and monitors third-party healthcare AI tools in real time, tracking model drift, human–AI interaction, and performance. It serves hospitals and radiologists, integrating into existing PACS/RIS workflows to make clinical AI safety and performance measurable.

1 investor